Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.50-0.17 (-3.00%)
At close: 04:00PM EST
5.50 0.00 (0.00%)
After hours: 04:02PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
14,444
144,927
33,215
34,505
Operating expenses
Research development
163,452
141,891
90,570
80,141
Selling general and administrative
77,796
69,261
30,775
24,748
Total operating expenses
242,059
209,420
121,345
104,889
Operating income or loss
-227,615
-64,493
-88,130
-70,384
Interest expense
4,878
2,910
2,924
502
Total other income/expenses net
-998
-1,045
981
-426
Income before tax
-231,362
-65,578
-89,127
-70,279
Income from continuing operations
-231,362
-65,578
-89,127
-70,279
Net income
-231,362
-65,578
-89,127
-70,279
Net income available to common shareholders
-231,362
-65,578
-89,127
-70,279
Basic EPS
-
-0.72
-1.12
-1.24
Diluted EPS
-
-0.72
-1.12
-1.24
Basic average shares
-
91,703
79,789
56,649
Diluted average shares
-
91,703
79,789
56,649
EBITDA
-
-56,721
-79,625
-62,174